Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis
about
A review of anatomical and mechanical factors affecting vertebral body integrityA review of the methods used to define glucocorticoid exposure and risk attribution when investigating the risk of fracture in a rheumatoid arthritis populationAdverse effects of oral corticosteroids in relation to dose in patients with lung diseaseFrom estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosisData driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis.Prevention and treatment of corticosteroid-induced osteoporosisEndogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitoninAre glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis?The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulationInfluence of inflammatory polyarthritis on quantitative heel ultrasound measurementsThe pharmacological management of drug-induced rheumatic disorders.Glucocorticoids and rheumatoid arthritis: back to the future?Should we look for osteoporosis in patients with rheumatoid arthritis?Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls.Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice.Bone quality and bone mass as assessed by quantitative ultrasound and dual energy x ray absorptiometry in women with rheumatoid arthritis: relationship with quadriceps strength.Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables.Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformitiesDisorders associated with acute rapid and severe bone loss.Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy.Osteoimmunology and osteoporosis.Height Restoration after Balloon Kyphoplasty in Rheumatoid Patients with Osteoporotic Vertebral Compression Fracture.Outcome of balloon kyphoplasty for the treatment of osteoporotic vertebral compression fracture in patients with rheumatoid arthritis.Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisEffects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.Vertebral fracture assessment in adolescents and young women with anorexia nervosa: a case series.Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer.Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis.Rheumatoid arthritis and incident fracture in women: a case-control study.Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study.Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome.Osteoporosis in inflammatory joint diseases.Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practice.Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study.Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis.Low-trauma fractures without osteoporosis.Osteoporosis-related simultaneous four joints fractures and dislocation after a seizure: a case reportThe impact of oral corticosteroid use on bone mineral density and vertebral fracture.
P2860
Q24791282-E908FC33-32ED-44DC-AE92-7FEBF507B6BBQ26748556-154CCC0E-1A05-4B0D-9BB3-3B2ED0009168Q28360540-7D8241AA-BEFB-41FC-9EAF-1088ADB0AAB5Q28385120-3622B6D0-4888-410D-8D01-1DED0BC76618Q30614235-BE5A54D7-68D0-4233-B60C-B2CC231076F9Q33628208-C0C5A73A-BB1F-4176-85D9-8CD0D3E396DBQ33806970-26B15464-B5C4-4F8E-B114-6C5C95B8F3C5Q33902085-6F3B0E4D-627E-49B3-ABA6-7A72A34242F0Q33912916-D6E50830-22B3-41A2-895E-DDD3D602D452Q34153137-4BD2C22B-2914-407C-9AB5-855EC78B0CE7Q34352571-E6E4B057-32BA-448D-9D31-E8C581670CADQ34515405-72A1178B-C87B-4D99-BD14-C1089B545747Q34972556-426A0A63-B6CE-47D2-89EE-1503CDBF5044Q35547936-EBC8FC02-4096-4A77-9A8D-FFF291B2D51EQ35549109-61AF2F48-717F-47FC-B323-31D23697D41CQ35550964-81657FBD-96E8-4F67-9C06-458C5ACC2C23Q35551474-E4E590C9-7790-4E53-937A-CF5A92A0ADD0Q35553780-75D06A2A-ACFD-43E5-A2C1-3E790D087AACQ35554362-7C93CD6F-A899-4F73-A600-C393F0946634Q35606552-CCF9C4AA-1A4B-4941-8578-302F25B0A3BDQ35809711-182A9540-5566-4C8D-AC92-6EE0C8D80A3DQ35840701-5544F33F-B5E0-4BC7-84EA-F673A95C9831Q35909172-2D6BD100-FB7C-45B3-B9BB-3206FFDDEED1Q36112262-7A53E1AD-C52F-4D0C-95F3-D58D9B599673Q36204190-960BE4EE-5F7D-45D5-88F4-51FBA58A4E74Q36979311-878BBD3D-CA9B-4CA8-BA4D-3C8F474C056EQ37096309-CFC4FE53-3F73-4BD0-9994-5D1DB92DEE88Q37195016-C39C607F-0A28-4F2D-A1EA-E6A04A5C9AB6Q37307876-DC6147B1-6BCB-454B-8ED7-C756AF8C399DQ37409538-69155BB6-23D6-4D63-AC6A-B2D0ED791E01Q37484958-D9B51088-0E6E-4DE3-83F5-DD8957BBC1F7Q37542785-E294785A-F14B-4B4F-953B-4232AC45B864Q37724214-CBB17257-B153-466F-8CDB-2C30E16B6B5DQ37765505-5106A5DD-E600-4B7C-B7D4-6D92BF88989FQ38221011-1EBAFE91-15F1-4332-B485-04E003C12029Q38896852-F0D810FF-84F5-4B41-88EC-3DE0E87FDD6BQ38958696-A4D9629F-C8E7-410C-9965-CB1211BB9DACQ38978699-4E1483F3-9B5C-4127-945C-B2B658B4EDACQ42120673-50D4668E-CAE1-4E49-AC02-8A92A1DEFBCAQ44120915-3F6D8AF3-6D4C-428A-ABFA-AC885F76FC82
P2860
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Risk of vertebral fracture and ...... d treated rheumatoid arthritis
@ast
Risk of vertebral fracture and ...... d treated rheumatoid arthritis
@en
Risk of vertebral fracture and ...... treated rheumatoid arthritis.
@nl
type
label
Risk of vertebral fracture and ...... d treated rheumatoid arthritis
@ast
Risk of vertebral fracture and ...... d treated rheumatoid arthritis
@en
Risk of vertebral fracture and ...... treated rheumatoid arthritis.
@nl
prefLabel
Risk of vertebral fracture and ...... d treated rheumatoid arthritis
@ast
Risk of vertebral fracture and ...... d treated rheumatoid arthritis
@en
Risk of vertebral fracture and ...... treated rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Risk of vertebral fracture and ...... d treated rheumatoid arthritis
@en
P2093
P2860
P304
P356
10.1136/ARD.54.10.801
P407
P577
1995-10-01T00:00:00Z